Skip to main content
. 2017 Jan 13;10:19–25. doi: 10.2147/IDR.S123646

Table 3.

MIC of antibiotics against fox AmpC and ESBL-producing isolates

Antibiotics AmpC AmpC + ESBL AmpC AmpC + ESBL P-value AmpC AmpC + ESBL AmpC AmpC + ESBL P-value




Salmonella choleraesuis Salmonella enteritidis Salmonella typhimurium Salmonella typhi
LAEV 0.19 (0.12–0.25) ND 0.19 (0.12–0.5) 0.2 (0.12–0.25) >0.05 0.47 (0.12–1.0) ND 0.77 (0.12–2.0) 1.07 (0.5–2.0) >0.05
IMP 0.18 (0.25–0.5) ND 0.42 (0.25–0.5) 0.42 (0.25–0.5) >0.05 0.56 (0.25–1.0) ND 0.71 (0.25–2.0) 1.07 (0.5–2.0) >0.05
COT 8.5 (4–16) ND 8 (4–16) 13.3 (8–16) >0.05 10 (4–16) ND 9.7 (4–16) 11.4 (4–16) >0.05
GEN 1.5 (1–2) ND 2.3 (1–4) 3.3 (2–4) >0.05 2.75 (1–4) ND 3 (1–4) 3.4 (1–4) >0.05
CAZ 6 (4–8) ND 5.3 (4–8) 13.3 (8–16) <0.05 4.5 (2–8) ND 7.1 (2–16) 19.4 (8–32) <0.05

Notes: MIC, mean (range), μg/mL. Difference in mean MIC values between AmpC + ESBL versus AmpC alone was analyzed by Student’s t-test. P<0.05 was considered to be significant.

Abbreviations: CAZ, ceftazidime; COT, cotrimoxazole; ESBL, extended-spectrum β-lactamase; GEN, gentamicin; IMP, imipenem; LAEV, levofloxacin; MIC, minimum inhibitory concentration; ND, not determined.